Results 31 to 40 of about 992,930 (196)

Computer-aided, resistance gene-guided genome mining for proteasome and HMG-CoA reductase inhibitors [PDF]

open access: yes, 2023
A new computer-assisted approach to resistance gene-directed genome mining is reported along with its use to identify fungal biosynthetic gene clusters that putatively produce proteasome and HMG-CoA reductase ...
Oakley, Berl R
core   +1 more source

Association between statins administration and glaucoma; a systematic review and meta-analysis of observational studies [PDF]

open access: yesJournal of Nephropharmacology
Introduction: Glaucoma is the leading cause of irreversible visual impairment in the world. Statins, primarily through their lipid-lowering effects, have been suggested to play a potential role in influencing the incidence of glaucoma. Consequently, this
Moloud Fakhri   +3 more
doaj   +1 more source

A systematic review and meta-analysis of the effect of statins on osteoporotic fractures [PDF]

open access: yesJournal of Nephropharmacology
Introduction: Statins can increase bone density and improve osteoporosis. As fractures are the worst outcome of osteoporosis, our study aimed to investigate the relationship between statins and osteoporotic fractures using a systematic review and meta ...
Shahin Asgari-Savadjani   +2 more
doaj   +1 more source

Effectiveness of statin treatment for recurrent stroke according to stroke subtypes [PDF]

open access: yesJournal of Medicine and Life Science
Understanding the effectiveness of statin treatment is essential for developing tailored stroke prevention strategies. We aimed to evaluate the efficacy of statin treatment in preventing recurrent stroke among patients with various ischemic stroke ...
Min-Surk Kye   +15 more
doaj   +1 more source

Chemoprevention of Gastric Cancer: Statins

open access: yesThe Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2017
Gastric cancer is one of the leading causes of cancer-related deaths worldwide. Because the gastric cancer-related mortality rate is expected to increase, chemo-preventive strategies for gastric cancer are required.
Sang Hyeon Choi, Gwang Ho Baik
doaj   +1 more source

Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance [PDF]

open access: yesJournal of Biological Chemistry, 2010
Epidemiological studies suggest that statins (hydroxymethylglutaryl-CoA reductase inhibitors) could reduce the risk of Alzheimer disease. Although one possible explanation is through an effect on beta-amyloid (Abeta) metabolism, its effect remains to be elucidated.
Mitsuru, Shinohara   +9 more
openaire   +2 more sources

Pleiotropic effects of the HMG-CoA reductase inhibitors

open access: yes, 2011
Christos G Mihos, Orlando SantanaColumbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USAAbstract: The HMG-CoA reductase inhibitors (statins) are used extensively in the treatment of hyperlipidemia.
Santana O   +3 more
core   +1 more source

Risk of new-onset diabetes associated with statin use

open access: yesSAGE Open Medicine, 2015
Objective: To identify and assess studies investigating the association between statins and new-onset diabetes and determine the clinical significance of this risk.
Robert D Beckett   +2 more
doaj   +1 more source

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks   +8 more
wiley   +1 more source

Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma [PDF]

open access: yes, 2008
BACKGROUND/AIMS: Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has been shown to inhibit growth and to induce apoptosis in human hepatocellular carcinoma (HCC) cells.
Straub, Gundula   +27 more
core   +1 more source

Home - About - Disclaimer - Privacy